ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

42 U.S.C. § 290ee–1First responder training

submitted 82 years ago by Pub. L. 114-198 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 833 words · no verdicts yet

in plain englishAI-generated · not legal advice

The Secretary gives grants to help first responders carry and give overdose-reversal drugs or devices. Grantees train responders, set up referral processes, and teach safety around fentanyl and other dangerous drugs. At least 20 percent of the funding must go to areas outside big cities.

(a) Program authorized The Secretary gives grants to states, local governmental entities, and Indian Tribes and Tribal organizations, so first responders and other key community sector members can administer an approved drug or device for emergency treatment of known or suspected overdose. (b) Application (1) In general An entity seeking a grant must apply to the Secretary, meeting the criteria in (2), in whatever form and with whatever information the Secretary requires. (2) Criteria The application must: (A) describe the evidence-based methodology and outcome measurements it will use to evaluate the program, and explain how those measurements will validly measure its impact; (B) describe how the program could be broadly replicated if shown to be effective; (C) identify the government and community agencies it will coordinate with; and (D) describe how it will ensure law enforcement agencies coordinate with state substance abuse and mental health agencies to identify protocols and resources available to overdose victims and families, including treatment and recovery resources. (c) Use of funds A grantee must use its grant to: (1) make the overdose-reversal drug or device available for first responders and other key community sector members to carry and administer; (2) train and provide resources for those people on carrying and administering it; (3) establish processes, protocols, and mechanisms for referral to appropriate treatment, which may include an outreach coordinator or team connecting people who received overdose-reversal drugs to follow-up services; and (4) train those people on safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs. (d) Technical assistance grants The Secretary must make a grant for technical assistance and training on using the overdose-reversal drug or device, referral mechanisms, and safety around fentanyl, carfentanil, and other dangerous drugs. (e) Geographic distribution The Secretary must ensure at least 20 percent of grant funds go to eligible entities located outside metropolitan statistical areas, taking into account rural communities' unique needs, including above-average opioid use disorder rates and shortages of prevention and treatment services. (f) Evaluation The Secretary must evaluate the grants to determine: (1) how many first responders and other key community sector members got the overdose-reversal drug or device; (2) how many overdoses they reversed using it; (3) how many service requests the grantee or subgrantee responded to for overdoses; (4) how much information overdose victims and families received about treatment services and admissions data; and (5) how many people were trained on fentanyl and carfentanil safety. (g) Other key community sectors This term includes substance use disorder treatment providers, EMS agencies, agencies and organizations working with prison and jail populations and offender reentry programs, health care providers, harm reduction groups, pharmacies, community health centers, tribal health facilities, and mental health providers. (h) Authorization of appropriations Congress authorized $57,000,000 for each of fiscal years 2026 through 2030.
the actual law source: uscode.house.gov ↗public domain
(a) Program authorized

The Secretary shall make grants to States, local governmental entities, and Indian Tribes and Tribal organizations (as defined in section 5304 of title 25) to allow first responders and members of other key community sectors to administer a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] for emergency treatment of known or suspected overdose.

(b) Application
(1) In general

An entity seeking a grant under this section shall submit an application to the Secretary—

(A)

that meets the criteria under paragraph (2); and

(B)

at such time, in such manner, and accompanied by such information as the Secretary may require.

(2) Criteria

An entity, in submitting an application under paragraph (1), shall—

(A)

describe the evidence-based methodology and outcome measurements that will be used to evaluate the program funded with a grant under this section, and specifically explain how such measurements will provide valid measures of the impact of the program;

(B)

describe how the program could be broadly replicated if demonstrated to be effective;

(C)

identify the governmental and community agencies with which the entity will coordinate to implement the program; and

(D)

describe how the entity will ensure that law enforcement agencies will coordinate with their corresponding State substance abuse and mental health agencies to identify protocols and resources that are available to overdose victims and families, including information on treatment and recovery resources.

(c) Use of funds

An entity shall use a grant received under this section to—

(1)

make a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected overdose available to be carried and administered by first responders and members of other key community sectors;

(2)

train and provide resources for first responders and members of other key community sectors on carrying and administering a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected overdose;

(3)

establish processes, protocols, and mechanisms for referral to appropriate treatment, which may include an outreach coordinator or team to connect individuals receiving overdose reversal drugs to followup services; and

(4)

train and provide resources for first responders and members of other key community sectors on safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs to protect themselves from exposure to such drugs and respond appropriately when exposure occurs.

(d) Technical assistance grants

The Secretary shall make a grant for the purpose of providing technical assistance and training on the use of a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected overdose, mechanisms for referral to appropriate treatment, and safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs.

(e) Geographic distribution

In making grants under this section, the Secretary shall ensure that not less than 20 percent of grant funds are awarded to eligible entities that are not located in metropolitan statistical areas (as defined by the Office of Management and Budget). The Secretary shall take into account the unique needs of rural communities, including communities with an incidence of individuals with opioid use disorder that is above the national average and communities with a shortage of prevention and treatment services.

(f) Evaluation

The Secretary shall conduct an evaluation of grants made under this section to determine—

(1)

the number of first responders and members of other key community sectors equipped with a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] for emergency treatment of known or suspected overdose;

(2)

the number of opioid, heroin, and other drug overdoses reversed by first responders and members of other key community sectors receiving training and supplies of a drug or device approved, cleared, or otherwise legally marketed under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected overdose, through a grant received under this section;

(3)

the number of responses to requests for services by the entity or subgrantee, to overdose;

(4)

the extent to which overdose victims and families receive information about treatment services and available data describing treatment admissions; and

(5)

the number of first responders and members of other key community sectors trained on safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs.

(g) Other key community sectors

In this section, the term “other key community sectors” includes substance use disorder treatment providers, emergency medical services agencies, agencies and organizations working with prison and jail populations and offender reentry programs, health care providers, harm reduction groups, pharmacies, community health centers, tribal health facilities, and mental health providers.

(h) Authorization of appropriations

To carry out this section, there are authorized to be appropriated $57,000,000 for each of fiscal years 2026 through 2030.

Source credit: (July 1, 1944, ch. 373, title V, § 546, as added Pub. L. 114–198, title II, § 202, July 22, 2016, 130 Stat. 715; amended Pub. L. 115–271, title VII, § 7002, Oct. 24, 2018, 132 Stat. 4007; Pub. L. 119–44, title I, § 106, Dec. 1, 2025, 139 Stat. 674.)

history & why it existsrecord from the source credit
  • 1944Enacted · Pub. L. 114-198 · 130 Stat. 715
  • 2018Amended · Pub. L. 115-271 · 132 Stat. 4007
  • 2025Amended · Pub. L. 119-44 · 139 Stat. 674

A history note hasn’t been published yet. The record shows enactment by Pub. L. 114-198 on 1944-07-01.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case